论文部分内容阅读
Nonsustained ventricular tachycardia(NSVT) is a well-recognized side effect during dobutamine stress echocardiography(DSE). This study sought to evaluate the prognostic implications of NSVT during DSE on 1,266 consecutive dobutamine stress echocardiograms performed over 1 year. NSVT, defined as< 3 consecutive ventricular premature beats, occurred in 65 of 1,266 patients(5.1% ). There was no absolute increased risk in all-cause mortality between the NSVT and no NSVT groups(22% vs 17% , p=0.15) during the 3-year follow-up. Survival curves generated by the Kaplan-Meier method also demonstrated no increased risk in mortality between the NSVT and no NSVT groups(p=0.43). When only studies with negative results for inducible ischemia were taken into account, survival curves showed no significant difference in all-cause mortality(p=0.26). Studies with negative results for inducible ischemia were also stratified according to the ejection fraction(EF). Patients without inducible ischemia and mildly reduced to normal EFs( >0.45) did not have significant differences in survival between the NSVT and no NSVT groups over the 3-year follow-up(p=0.86). However, patients without inducible ischemia and moderately reduced EFs(0.35 to 0.45) who had NSVT during DSE had significantly reduced survival over the follow-up(p=0.01).
Nonsustained ventricular tachycardia (NSVT) is a well-recognized side effect during dobutamine stress echocardiography (DSE). This study sought to evaluate the prognostic implications of NSVT during DSE on 1,266 consecutive dobutamine stress echocardiograms performed over 1 year. NSVT, defined as <3 consecutive was born in 65 of 1,266 patients (5.1%). There was no absolute increased risk in all-cause mortality between the NSVT and no NSVT groups (22% vs 17%, p = 0.15) during the 3-year follow-up. Survival curves generated by the Kaplan-Meier method also demonstrated no increased risk in mortality between the NSVT and no NSVT groups (p = 0.43). When only studies with negative results for inducible ischemia were taken into account, survival curves showed showed no significant difference in all-cause mortality (p = 0.26). Studies with negative results for inducible ischemia were also stratified according to the ejection fraction (EF). Patients without inducible ischemia and mil However, those patients who did not have significant differences in survival between the NSVT and no NSVT groups over the 3-year follow-up (p = 0.86). However, patients without inducible ischemia and moderately reduced EFs (0.35 to 0.45) who had NSVT during DSE had significantly reduced survival over the follow-up (p = 0.01).